Showing results (71-80 of 112) with videos related to
Sort By:
Pageof 12
The European Journal of Neuroscience|March 24, 2021
Striatal transcriptome changes linked to drug-induced repetitive behaviorsJill R Crittenden, Theresa A Gipson, Anne C Smith, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 3, 2025
TGFβ limits proximal CD8+ TCR signaling via PTPN22 following strong and moderate agonismAndrew J Gunderson, Kelley Jordan, Tomoko Yamazaki, et al.The Journal of Clinical Investigation|May 12, 2007
Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type IIIWolfgang Bergmeier, Tobias Goerge, Hong-Wei Wang, et al.Iscience|January 26, 2026
Fluorescence tracking Treg movement identifies anti-CCR8 and radiation as a therapeutic combinationDavid J Friedman, Sina Ramin, Tiffany Blair, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1996
Toxicities of total-body irradiation for pediatric bone marrow transplantationR H Chou, G B Wong, J H Kramer, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2026
Fluorescence tracking CD8 T cells from tumor-draining lymph nodes to irradiated tumors and their activation in the tumor environmentDavid Friedman, Gwen Kramer, Alejandro F Alice, et al.Proceedings of the National Academy of Sciences of the United States of America|January 28, 2009
Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapyJill R Crittenden, Ippolita Cantuti-Castelvetri, Esen Saka, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in miceMichael J Gough, Marka R Crittenden, MaryClare Sarff, et al.Blood|June 1, 1990
Further studies on growth factor production by the TC-1 stromal cell line: pre-B stimulating activityT A Woodward, I K McNiece, P L Witte, et al.Oral Oncology|November 29, 2015
OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironmentR Bryan Bell, Rom S Leidner, Marka R Crittenden, et al.Pageof 12